Pharmacogenomics (PGx) Fluoropyrimidines DPYD Test
A targeted pharmacogenomic test evaluating the DPYD gene to predict fluoropyrimidine treatment efficacy and side effect risk, powered by the Helix Exome+® platform.
6-9 days
≤ 5 minutes
Test Description
This test evaluates 1 gene associated with response to certain medications including fluoropyrimidines. Results from this test may help in predicting treatment efficacy and risk of side effects for these drugs.
Have Questions?
Our team is available Monday through Friday, 9am-5pm Pacific Time.
Indications for Testing
Patients in whom fluoropyrimidines are being considered, have been ineffective, or caused side effects.
Methodology
This test utilizes next-generation sequencing to determine star alleles and metabolizer status for DPYD.
Technical Specifications
DPYD: *1, *2A, *3, *4, *6-*8, *9B, *10-*13, HapB3, rs150036960, rs72549310, rs80081766, rs150385342, rs141462178, rs200562975, rs2297595, rs139834141, rs6670886, rs115232898, rs72549308, rs72549307, r...
Genes Tested
Showing 1 of 1 genes in this panel